IsoRay Inc Executives

ISRDelisted Stock  USD 0.38  0.01  2.70%   
IsoRay employs about 66 people. The company is managed by 14 executives with a total tenure of roughly 56 years, averaging almost 4.0 years of service per executive, having 4.71 employees per reported executive. Discussion of IsoRay's management performance can provide insight into the enterprise performance.
Lori Woods  CEO
Interim Chief Executive Officer, Director
Michael McCormick  Chairman
Independent Chairman of the Board
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

IsoRay Management Team Effectiveness

The company has Return on Asset of (0.1085) % which means that on every $100 spent on assets, it lost $0.1085. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1741) %, meaning that it generated no profit with money invested by stockholders. IsoRay's management efficiency ratios could be used to measure how well IsoRay manages its routine affairs as well as how well it operates its assets and liabilities.

IsoRay Workforce Comparison

IsoRay Inc is currently regarded as number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 248,138. IsoRay adds roughly 66.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Net Profit Margin of (1.16) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (1.21) %, which entails that for every $100 of revenue, it lost $1.21.

IsoRay Notable Stakeholders

An IsoRay stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as IsoRay often face trade-offs trying to please all of them. IsoRay's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting IsoRay's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Lori WoodsInterim Chief Executive Officer, DirectorProfile
Michael McCormickIndependent Chairman of the BoardProfile
William CavanaghVice President - Research and DevelopmentProfile
Michael KrachonVice President, Director of Sales and MarketingProfile
Jennifer StreeterInterim Chief Operating Officer, Vice President of Human ResourcesProfile
Jonathan HuntChief Financial Officer, Co-Principal Financial OfficerProfile
Alan HoffmannIndependent DirectorProfile
Philip VitaleIndependent DirectorProfile
Mark AustinPrincipal Accounting Officer, Co-Principal Financial Officer, ControllerProfile
Lisa LauerVice President - Business DevelopmentProfile
Lori HolmesWoodsCEO DirectorProfile
Mark CPAController, FinProfile
William IIIChief OfficerProfile
Krista ClineSenior Director of Operations, Corporate SecretaryProfile

About IsoRay Management Performance

The success or failure of an entity such as IsoRay Inc often depends on how effective the management is. IsoRay management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of IsoRay management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the IsoRay management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Isoray, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. Isoray, Inc. was founded in 1998 and is based in Richland, Washington. Isoray operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 66 people.

IsoRay Workforce Analysis

Traditionally, organizations such as IsoRay use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare IsoRay within its industry.

IsoRay Manpower Efficiency

Return on IsoRay Manpower

Revenue Per Employee163.6K
Revenue Per Executive771.1K
Net Loss Per Employee110.2K
Net Loss Per Executive519.4K
Working Capital Per Employee189.9K
Working Capital Per Executive895.4K
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in IsoRay Stock

If you are still planning to invest in IsoRay Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IsoRay's history and understand the potential risks before investing.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments